ECG in Primary Care: A New Era of AI-Powered Interpretation (Webinar Summary)

  • Powerful Medical
  • September 27, 2023
  • 3 min to read
Webinar banner with speakers Dr. Yassir Javaid, Dr. Anthony Demolder and Dr. Fakhar Khan on ECG in primary care

In our webinar ‘ECG Interpretation in Primary Care: A New Era,’ Drs. Javaid and Khan discuss ECG interpretation and AI’s role in diagnostic accuracy, aiding primary care providers with best practices and AI tools.

In our most recent webinar, “ECG Interpretation in Primary Care: A New Era of Getting It Right Every Time,” esteemed guest speakers Dr. Yassir Javaid and Dr. Fakhar Khan shed light on critical aspects of ECG interpretation and the role of AI in enhancing diagnostic accuracy. The session specifically catered to the needs of primary care providers, illuminating the latest best practices and AI-powered tools that could help refine the patient journey and foster trust within healthcare settings.

Navigating the Complex Landscape of ECG Interpretation in Primary Care

ECG interpretation has been a complex skill often perceived as the realm of cardiologists. However, primary care clinicians are frequently the first point of contact for patients experiencing symptoms that necessitate an ECG. They are the gatekeepers to specialised care. Incorrect interpretations can compromise patient safety, leading to unnecessary referrals or, worse, missed or delayed diagnoses. This makes the need for fast, reliable ECG interpretation all the more critical.

PMcardio: Transforming ECG Interpretation at the Point of Care

During the webinar, the distinguished experts demonstrated the transformative capabilities of PMcardio, the AI-powered clinical assistant. Designed for seamless integration into primary care settings, PMcardio reads and interprets any 12-lead ECG in under five seconds, offering diagnostic and treatment recommendations. This Class IIb medical device is not just a technological marvel but a practical tool that ensures every healthcare professional can interpret ECGs with the confidence and precision of a seasoned cardiologist.

Identifying Red Flags: Atrial Fibrillation & Heart Block

The presentation by Dr. Khan delved into the identification of red flags in ECGs, such as atrial fibrillation and heart block. These are critical conditions that demand immediate attention and are commonly missed or misinterpreted in primary care settings. The utility of PMcardio in these scenarios was underscored, as the device has proven its effectiveness in identifying such abnormalities with exceptional sensitivity and specificity.

AI Integration in Primary Care: The Time Is Now

Dr. Javaid discussed the timeliness of integrating AI technology, such as PMcardio, into primary care. The urgency is evident; as the healthcare industry evolves, primary care providers must equip themselves with the tools necessary to deliver precise, timely care. AI-powered solutions minimise diagnostic errors, streamline patient referrals to secondary care and ultimately improve patient outcomes.

Share this article

  • Share on Facebook
  • Share on X
  • Share on Linkedin
  • Share via e-mail
  • Copy the link
About PMcardio logo

About PMcardio

PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.

About Product

About Powerful Medical  logo

About Powerful Medical

Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.

About Us